TRIM59 and lung carcinoma: TRIM59 is not only involved in the molecular mechanism of lung cancer, but is also closely correlated to the clinicopathological characteristics and prognosis of lung cancer.[25–29] The increased expression of TRIM59 indicates a poor clinical prognosis in patients with lung cancer, and may be used as a biomarker to evaluate the prognosis of patients suffering from lung cancer.